GB8519310D0 - Granular active substances - Google Patents

Granular active substances

Info

Publication number
GB8519310D0
GB8519310D0 GB858519310A GB8519310A GB8519310D0 GB 8519310 D0 GB8519310 D0 GB 8519310D0 GB 858519310 A GB858519310 A GB 858519310A GB 8519310 A GB8519310 A GB 8519310A GB 8519310 D0 GB8519310 D0 GB 8519310D0
Authority
GB
United Kingdom
Prior art keywords
active substances
granular active
granular
substances
active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB858519310A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Haleon CH SARL
Original Assignee
Haleon CH SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haleon CH SARL filed Critical Haleon CH SARL
Priority to GB858519310A priority Critical patent/GB8519310D0/en
Publication of GB8519310D0 publication Critical patent/GB8519310D0/en
Priority to PH34052A priority patent/PH23531A/en
Priority to LU86523A priority patent/LU86523A1/de
Priority to US06/888,610 priority patent/US4728513A/en
Priority to CH3001/86A priority patent/CH670566A5/de
Priority to GB8618153A priority patent/GB2178313B/en
Priority to DE19863625458 priority patent/DE3625458A1/de
Priority to IL79537A priority patent/IL79537A/xx
Priority to FI863074A priority patent/FI863074A7/fi
Priority to SE8603247A priority patent/SE8603247L/
Priority to PT83093A priority patent/PT83093B/pt
Priority to ES8600694A priority patent/ES2000577A6/es
Priority to IT48323/86A priority patent/IT1195985B/it
Priority to FR868610952A priority patent/FR2585570B1/fr
Priority to DK361786A priority patent/DK361786A/da
Priority to ZA865691A priority patent/ZA865691B/xx
Priority to NZ217028A priority patent/NZ217028A/xx
Priority to NL8601961A priority patent/NL8601961A/nl
Priority to JP61177897A priority patent/JPS6229514A/ja
Priority to HU863240A priority patent/HU196304B/hu
Priority to AU60685/86A priority patent/AU596804B2/en
Priority to GR862017A priority patent/GR862017B/el
Priority to AT2056/86A priority patent/AT392901B/de
Priority to BE0/216995A priority patent/BE905200A/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB858519310A 1985-07-31 1985-07-31 Granular active substances Pending GB8519310D0 (en)

Priority Applications (24)

Application Number Priority Date Filing Date Title
GB858519310A GB8519310D0 (en) 1985-07-31 1985-07-31 Granular active substances
PH34052A PH23531A (en) 1985-07-31 1986-07-22 A granular delayed-release form of pharmaceutically active substances
LU86523A LU86523A1 (fr) 1985-07-31 1986-07-23 Granulaere form mit verzoegerter freisetzung von pharmazeutisch wirksamen substanzen
US06/888,610 US4728513A (en) 1985-07-31 1986-07-23 Granular delayed-release form of pharmaceutically active substances
CH3001/86A CH670566A5 (enExample) 1985-07-31 1986-07-24
GB8618153A GB2178313B (en) 1985-07-31 1986-07-25 A granular delayed-release form of pharmaceutically active substances
DE19863625458 DE3625458A1 (de) 1985-07-31 1986-07-28 Granulaere form mit verzoegerter freisetzung von pharmazeutisch wirksamen substanzen
IL79537A IL79537A (en) 1985-07-31 1986-07-28 Process for manufacture of a granular delayed-release form of pharmaceutically active substances and the granules produced thereby
FI863074A FI863074A7 (fi) 1985-07-31 1986-07-28 Farmaseuttisesti aktiivisten aineiden rakeinen, hidasluovutteinen muoto.
FR868610952A FR2585570B1 (fr) 1985-07-31 1986-07-29 Procede de preparation d'une forme granulaire a liberation retardee d'un principe actif et forme granulaire obtenue
PT83093A PT83093B (pt) 1985-07-31 1986-07-29 Processo de preparacao de uma forma granulada de libertacao retardada de substancias farmaceuticamente activas contendo um poli-ester de acido acrilico ou metacrilico
SE8603247A SE8603247L (sv) 1985-07-31 1986-07-29 Granulerad form med fordrojd frigoring av farmaceutiskt aktiva substanser
ES8600694A ES2000577A6 (es) 1985-07-31 1986-07-29 Procedimiento para la preparacion de una forma granulada, de liberacion retardada de una sustancia farmaceuticamente activa
IT48323/86A IT1195985B (it) 1985-07-31 1986-07-29 Procedimento per produrre una forma di messa in liberta' ritardata granulare di sostanza attiva e prodotto cosi' ottenuto
BE0/216995A BE905200A (fr) 1985-07-31 1986-07-30 Procede de preparation d'une forme granulaire a liberation retardee d'un principe actif et forme granulaire obtenue.
NZ217028A NZ217028A (en) 1985-07-31 1986-07-30 Granular delayed release compositions: granules coated with polyacrylic acid ester/ethyl cellulose mixture
ZA865691A ZA865691B (en) 1985-07-31 1986-07-30 A granular delayed-release form of pharmaceutically active substances
DK361786A DK361786A (da) 1985-07-31 1986-07-30 Granulaere farmaceutiske praeparater med forskudt afgivelse
NL8601961A NL8601961A (nl) 1985-07-31 1986-07-30 Granulaire vorm van farmaceutisch werkzame stoffen met vertraagde afgifte.
JP61177897A JPS6229514A (ja) 1985-07-31 1986-07-30 医薬活性物質の遅延放出形粒状物及びその製造方法
HU863240A HU196304B (en) 1985-07-31 1986-07-30 Process for production of granulates of medical active substances with delaying effect
AU60685/86A AU596804B2 (en) 1985-07-31 1986-07-30 A granular delayed-release form of pharmaceutically active substances
GR862017A GR862017B (en) 1985-07-31 1986-07-30 Granular delayed-release form of pharmaceutically active substances
AT2056/86A AT392901B (de) 1985-07-31 1986-07-30 Verfahren zur herstellung einer granulaeren form mit verzoegerter freisetzung von pharmazeutisch wirksamen substanzen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858519310A GB8519310D0 (en) 1985-07-31 1985-07-31 Granular active substances

Publications (1)

Publication Number Publication Date
GB8519310D0 true GB8519310D0 (en) 1985-09-04

Family

ID=10583125

Family Applications (2)

Application Number Title Priority Date Filing Date
GB858519310A Pending GB8519310D0 (en) 1985-07-31 1985-07-31 Granular active substances
GB8618153A Expired GB2178313B (en) 1985-07-31 1986-07-25 A granular delayed-release form of pharmaceutically active substances

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB8618153A Expired GB2178313B (en) 1985-07-31 1986-07-25 A granular delayed-release form of pharmaceutically active substances

Country Status (23)

Country Link
US (1) US4728513A (enExample)
JP (1) JPS6229514A (enExample)
AT (1) AT392901B (enExample)
AU (1) AU596804B2 (enExample)
BE (1) BE905200A (enExample)
CH (1) CH670566A5 (enExample)
DE (1) DE3625458A1 (enExample)
DK (1) DK361786A (enExample)
ES (1) ES2000577A6 (enExample)
FI (1) FI863074A7 (enExample)
FR (1) FR2585570B1 (enExample)
GB (2) GB8519310D0 (enExample)
GR (1) GR862017B (enExample)
HU (1) HU196304B (enExample)
IL (1) IL79537A (enExample)
IT (1) IT1195985B (enExample)
LU (1) LU86523A1 (enExample)
NL (1) NL8601961A (enExample)
NZ (1) NZ217028A (enExample)
PH (1) PH23531A (enExample)
PT (1) PT83093B (enExample)
SE (1) SE8603247L (enExample)
ZA (1) ZA865691B (enExample)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4726952A (en) * 1983-08-11 1988-02-23 Mission Pharmacal Slow-release sodium fluoride tablet, method of making, and method of treatment of osteoporosis
JPH0830005B2 (ja) * 1985-09-25 1996-03-27 ゲルゲリイ、ゲルハルト 崩壊性錠剤とその製造方法
CH669523A5 (enExample) * 1986-06-25 1989-03-31 Mepha Ag
US4859467A (en) * 1986-09-25 1989-08-22 Colgate-Palmotive Company Sustained release fluoride composition
GB8707421D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
GB8707416D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
DE3712095A1 (de) * 1987-04-10 1988-10-20 Lentia Gmbh Bindemittelfreies granulat mit verzoegerter wirkstoffabgabe
US5178868A (en) * 1988-10-26 1993-01-12 Kabi Pharmacia Aktiebolaq Dosage form
IT1227899B (it) * 1988-12-23 1991-05-14 Poli Ind Chimica Spa Rivestimento totale o parziale di principi attivi farmaceutici e relative composizioni
US4970081A (en) * 1989-01-03 1990-11-13 Sterling Drug Inc. Controlled-release, low-dose aspirin formulation and method of treating vascular occlusive disease therewith
AU622254B2 (en) * 1989-01-03 1992-04-02 Sterling Drug Inc. Controlled-release, low dose aspirin
US5084287A (en) * 1990-03-15 1992-01-28 Warner-Lambert Company Pharmaceutically useful micropellets with a drug-coated core and controlled-release polymeric coat
US5013728A (en) * 1990-05-04 1991-05-07 Colgate - Palmolive Company Composition for treating osteoporosis and hormonal imbalance
US5153005A (en) * 1990-12-11 1992-10-06 Colgate-Palmolive Company Composition and method for preventing fluorosis
AU664561B2 (en) * 1991-06-21 1995-11-23 University Of Cincinnati, The Orally administrable therapeutic proteins and method of making
US6613332B1 (en) 1991-06-21 2003-09-02 The University Of Cincinnati Oral administration of therapeutic proteins
US5266331A (en) * 1991-11-27 1993-11-30 Euroceltique, S.A. Controlled release oxycodone compositions
US5681585A (en) * 1991-12-24 1997-10-28 Euro-Celtique, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
US5286493A (en) * 1992-01-27 1994-02-15 Euroceltique, S.A. Stabilized controlled release formulations having acrylic polymer coating
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US5273760A (en) * 1991-12-24 1993-12-28 Euroceltigue, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
US5958459A (en) * 1991-12-24 1999-09-28 Purdue Pharma L.P. Opioid formulations having extended controlled released
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
US7070806B2 (en) * 1992-01-27 2006-07-04 Purdue Pharma Lp Controlled release formulations coated with aqueous dispersions of acrylic polymers
FI101039B (fi) * 1992-10-09 1998-04-15 Eeva Kristoffersson Menetelmä lääkepellettien valmistamiseksi
US20080075781A1 (en) * 1992-11-25 2008-03-27 Purdue Pharma Lp Controlled release oxycodone compositions
DK0603992T4 (da) * 1992-12-22 2001-03-05 Univ Cincinnati Oral indgivelse af immunologisk aktive biomolekyler og andre terapeutiske proteiner
DE4319649A1 (de) * 1993-03-18 1994-09-22 Asta Medica Ag Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
US20070275062A1 (en) * 1993-06-18 2007-11-29 Benjamin Oshlack Controlled release oxycodone compositions
US7740881B1 (en) 1993-07-01 2010-06-22 Purdue Pharma Lp Method of treating humans with opioid formulations having extended controlled release
IL110014A (en) * 1993-07-01 1999-11-30 Euro Celtique Sa Solid controlled-release oral dosage forms of opioid analgesics
US5879705A (en) * 1993-07-27 1999-03-09 Euro-Celtique S.A. Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
US20020006438A1 (en) * 1998-09-25 2002-01-17 Benjamin Oshlack Sustained release hydromorphone formulations exhibiting bimodal characteristics
US5674529A (en) * 1995-06-06 1997-10-07 Church & Dwight Co., Inc. Alkalinizing potassium salt controlled release preparations
FR2760190B1 (fr) * 1997-02-28 1999-04-09 Adir Composition pharmaceutique pour la liberation programmee de dexfenfluramine
US6306438B1 (en) 1997-07-02 2001-10-23 Euro-Celtique, S.A. Stabilized sustained release tramadol formulations
US6806294B2 (en) 1998-10-15 2004-10-19 Euro-Celtique S.A. Opioid analgesic
FR2785539B1 (fr) * 1998-11-06 2004-04-09 Prographarm Laboratoires Particules enrobees d'ibuprofene cristallin granule
DE19928312A1 (de) * 1999-06-16 2000-12-21 Schering Ag Arzneimittelzubereitung mit verzögerter Wirkstoffabgabe
BR0013720A (pt) 1999-09-02 2002-07-23 Nostrum Pharmaceuticals Inc Formulação em pelota de liberação controlada
EP2295043A1 (en) 1999-10-29 2011-03-16 Euro-Celtique S.A. Controlled release hydrocodone formulations
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
AU2002227383B2 (en) 2000-10-30 2004-07-08 Euro-Celtique S.A. Controlled release hydrocodone formulations
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
UA81224C2 (uk) * 2001-05-02 2007-12-25 Euro Celtic S A Дозована форма оксикодону та її застосування
US6884619B2 (en) 2001-07-17 2005-04-26 Yale University Inhibition of BEHAB cleavage and primary central nervous system (CNS) tumors
DE10152469A1 (de) * 2001-10-24 2003-06-26 Gruenenthal Gmbh 3-(3-Dimethylamino-1-ethyl-2-methyl-propyl)phenol enthaltendes Arzneimittel mit verzögerter Wirkstofffreisetzung
PE20030527A1 (es) 2001-10-24 2003-07-26 Gruenenthal Chemie Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
US7410965B2 (en) * 2002-05-29 2008-08-12 Gruenenthal Gmbh Delayed release pharmaceutical composition containing 1-dimethyl-amino-3-(3-methoxyphenyl)-2-methyl-pentan-3-ol
US20050100577A1 (en) * 2003-11-10 2005-05-12 Parker Theodore L. Expandable medical device with beneficial agent matrix formed by a multi solvent system
US7387793B2 (en) * 2003-11-14 2008-06-17 Eurand, Inc. Modified release dosage forms of skeletal muscle relaxants
WO2005095950A1 (en) * 2004-03-30 2005-10-13 Pfizer Products Inc. Method and device for evaluation of pharmaceutical compositions
DE102004035938A1 (de) * 2004-07-23 2006-02-16 Röhm GmbH & Co. KG Verfahren zur Herstellung von überzogenen Arzneiformen mit stabilem Wirkstofffreigabeprofil
EP1825866A4 (en) * 2004-12-03 2008-03-12 Takeda Pharmaceutical SOLID PREPARATION
JP5124267B2 (ja) * 2005-02-25 2013-01-23 武田薬品工業株式会社 顆粒の製造方法
CA2671197A1 (en) * 2006-07-21 2008-01-24 Lab International Srl Hydrophobic abuse deterrent delivery system
DE102006051020A1 (de) * 2006-10-26 2008-04-30 Evonik Röhm Gmbh Verwendung von (Meth)acrylat-Copolymeren in Retard-Arzneiformen zur Verringerung des Einflusses von Ethanol auf die Wirkstofffreisetzung
WO2008065502A1 (en) * 2006-11-29 2008-06-05 Pfizer Products Inc. Pharmaceutical compositions based on a) nanoparticles comprising enteric polymers and b) casein
US20100119612A1 (en) * 2007-04-17 2010-05-13 Bend Research, Inc Nanoparticles comprising non-crystalline drug
WO2008135828A2 (en) * 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a drug, ethylcellulose, and a bile salt
US20100080852A1 (en) * 2007-05-03 2010-04-01 Ronald Arthur Beyerinck Phamaceutical composition comprising nanoparticles and casein
US8703204B2 (en) * 2007-05-03 2014-04-22 Bend Research, Inc. Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and anon-ionizable polymer
US20080279930A1 (en) * 2007-05-07 2008-11-13 Bernd Terhaag Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof
WO2008149230A2 (en) 2007-06-04 2008-12-11 Pfizer Products Inc. Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate
EP2162120B1 (en) * 2007-06-04 2016-05-04 Bend Research, Inc Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
US20100215747A1 (en) * 2007-07-13 2010-08-26 Corey Jay Bloom Nanoparticles comprising ionizable, poorly water soluble cellulosic polymers
WO2009011367A1 (ja) * 2007-07-17 2009-01-22 Asahi Kasei Chemicals Corporation 水系組成物
WO2009073215A1 (en) * 2007-12-06 2009-06-11 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
EP2240162A4 (en) * 2007-12-06 2013-10-09 Bend Res Inc NANOTE PARTICLES WITH A NON-IONIZABLE POLYMER AND AN AMIN-FUNCTIONALIZED METHACRYLATE COPOLYMER
CN103432093B (zh) * 2013-08-31 2015-03-25 西南大学 甲磺酸普立地诺骨架缓释片及其制备方法
CA3018328A1 (en) 2014-10-31 2016-04-30 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US904848A (en) * 1908-05-27 1908-11-24 William W Devore Artificial whirlpool.
AT64577B (de) * 1913-04-28 1914-04-25 Carl Georg Rodeck Volksbelustigungsvorrichtung mit sich drehenden Plattformen.
US1689138A (en) * 1927-10-15 1928-10-23 Playground & Gymnasium Equipme Bathers' inclined rotary water platform
NL137652C (enExample) * 1962-07-11
DE2010110A1 (de) * 1970-03-04 1971-09-16 Farbenfabriken Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von Mikrokapseln mit Hilfe von synthetischen Koazervaten
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
JPS52139715A (en) * 1976-05-14 1977-11-21 Nippon Kayaku Co Ltd Coated granules of alkali polyacrylate
EP0052075A1 (de) * 1980-11-12 1982-05-19 Ciba-Geigy Ag Körnige Arzneimittel-Retardform
JPS5867616A (ja) * 1981-10-15 1983-04-22 Tanabe Seiyaku Co Ltd 腸溶性マイクロカプセル
US4543886A (en) * 1983-03-09 1985-10-01 Intamin Inc. Amusement ride including a rotating loading terminal
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
CH658188A5 (de) * 1984-03-23 1986-10-31 Ciba Geigy Ag Lagerstabile schnellzerfallende pharmazeutische presslinge.
CH666405A5 (de) * 1985-06-24 1988-07-29 Ciba Geigy Ag Feste, haltbare darreichungsformen mit elastischem filmueberzug.
GB8521494D0 (en) * 1985-08-29 1985-10-02 Zyma Sa Controlled release tablet

Also Published As

Publication number Publication date
AT392901B (de) 1991-07-10
CH670566A5 (enExample) 1989-06-30
PT83093A (en) 1986-08-01
US4728513A (en) 1988-03-01
FR2585570A1 (fr) 1987-02-06
AU596804B2 (en) 1990-05-17
ATA205686A (de) 1990-12-15
FI863074A0 (fi) 1986-07-28
ZA865691B (en) 1987-03-25
ES2000577A6 (es) 1988-03-01
DE3625458A1 (de) 1987-02-12
LU86523A1 (fr) 1987-02-04
GB2178313A (en) 1987-02-11
IL79537A (en) 1991-01-31
HUT41630A (en) 1987-05-28
GR862017B (en) 1986-12-23
NZ217028A (en) 1989-08-29
IT8648323A0 (it) 1986-07-29
DK361786D0 (da) 1986-07-30
GB2178313B (en) 1989-08-23
SE8603247D0 (sv) 1986-07-29
IT1195985B (it) 1988-11-03
GB8618153D0 (en) 1986-09-03
FI863074L (fi) 1987-02-01
NL8601961A (nl) 1987-02-16
AU6068586A (en) 1987-02-05
IL79537A0 (en) 1986-10-31
PH23531A (en) 1989-08-25
PT83093B (pt) 1989-01-30
FR2585570B1 (fr) 1990-03-23
SE8603247L (sv) 1987-02-01
FI863074A7 (fi) 1987-02-01
HU196304B (en) 1988-11-28
DK361786A (da) 1987-02-01
JPS6229514A (ja) 1987-02-07
BE905200A (fr) 1987-01-30

Similar Documents

Publication Publication Date Title
EP0214818A3 (en) Active compounds
GB8504099D0 (en) Physiologically active substances
GB8615043D0 (en) Solid stable dosage forms
GB2177919B (en) Synergistic biologically active substances
GB8522056D0 (en) Forming substances
GB2177917B (en) Dermatologically active substances
GB8919310D0 (en) Biologically active substances
GB8511846D0 (en) Fertilizer
GB8611629D0 (en) Substances
GB8521795D0 (en) Granular applicator
GB8503260D0 (en) Active compounds
GB8523051D0 (en) Active compounds
GB8516391D0 (en) Active compounds
GB8530311D0 (en) Active compounds
GB8516390D0 (en) Active compounds
GB8503259D0 (en) Active compounds
GB8520620D0 (en) Active compounds
GB8531632D0 (en) Active compounds
GB8529457D0 (en) Active compounds
GB8518969D0 (en) Active compounds
GB8527713D0 (en) Active compounds
GB8530312D0 (en) Active compounds
GB8511237D0 (en) Active compounds
GB8503330D0 (en) Active compounds
GB8531633D0 (en) Active compounds